Xermelo 250 mg, Filmtabletten

7680663740012 CH-66374 Filmtabletten
Xermelo 250 mg, Filmtabletten
Xermelo 250 mg, Filmtabletten
Xermelo 250 mg, Filmtabletten
1 / 3
google

Article details

Package size
90
Selling units
90
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/04/2023
Patient information leaflet
Français
11/04/2023
Patient information leaflet
Italien
11/04/2023
Summary of Product Characteristics
Allemand
11/04/2023
Summary of Product Characteristics
Français
11/04/2023
Summary of Product Characteristics
Italien
11/04/2023

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
327.9 MG Substance WIZUS
(N/A)
237.8 MG Substance WIZUS
(N/A)
167.91 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.54 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
66374
Drug name
Xermelo, Filmtabletten
Galenic form
FILM
ATC Code
A16AX15
Authorization status
Z
Dispensing category
B
First authorization
28/03/2018
Authorization expiration date
31/12/9999
IT Number
07.16.4.
Domain
Human medicine
Field of application
Karzinoid-Syndrom-bedingte Diarrhö

Package details

Description (FR)
XERMELO cpr pell 250 mg 90 pce
Description (DE)
XERMELO Filmtabl 250 mg 90 Stk
Market launch
28/03/2018
Narcotic (BTM)
No